Anticipating Docebo's Earnings Report
Docebo (NASDAQ: DCBO) is preparing to release its latest quarterly earnings report. Investors are looking forward to this moment, eager for signs of how the company has been performing. With significant attention on its earnings per share (EPS), analysts estimate that Docebo will post an EPS of $0.32.
Market Expectations
The upcoming earnings announcement is generating a lot of market buzz. Investors are hopeful that Docebo will exceed current estimates and provide optimistic guidance for the upcoming quarter, which can heavily influence stock prices. Understanding the implications of guidance is vital, especially for those new to investing.
Earnings Performance History
Performance Overview
Reflecting on the previous quarter, Docebo beat EPS expectations by $0.10, although the stock saw a 0.0% drop in value the following day. Such fluctuations following earnings reports are not uncommon and illustrate the unpredictable nature of stock market reactions.
Tracking the Changes
Analyzing Docebo's past earnings results, the following data presents insights into the company's performance:
Quarter-wise EPS Estimates and Actuals:
- Q2 2025: Estimate $0.2, Actual $0.3
- Q1 2025: Estimate $0.22, Actual $0.27
- Q4 2024: Estimate $0.26, Actual $0.28
- Q3 2024: Estimate $0.17, Actual $0.27
Understanding Docebo's Stock Performance
Current Share Price Analysis
As of the latest data, Docebo shares were priced at $25.18, reflecting an unfortunate 52.77% decrease over the past year. These figures may signal caution among long-term investors, especially as earnings approaches.
Analyst Insights and Consensus Ratings
Professional market analysts' perspectives are invaluable. Currently, Docebo holds a consensus rating of 'Buy' based on four analyst ratings. The average one-year price target for its stock is $36.25, suggesting a notably positive upside potential of approximately 43.96%.
Comparative Peer Analysis
Industry Competitors
To provide a comprehensive view, examining the ratings of Docebo's peers can add depth. Companies such as i3 Verticals, Similarweb, and Riskified have been evaluated for their market stances:
- i3 Verticals: Rated 'Buy' with a one-year price target of $37.0, indicating a 46.94% upside.
- Similarweb: Rated 'Outperform' with a one-year price target of $14.0, which suggests a 44.4% downside.
- Riskified: Rated 'Neutral' with a one-year target of $5.56, reflecting a significant 77.92% downside.
Summary of Peer Metrics
In comparing these companies, key performance metrics highlight Docebo's strengths and weaknesses:
| Company | Consensus | Revenue Growth | Gross Profit | Return on Equity |
|---|---|---|---|---|
| Docebo | Buy | 14.47% | $49.15M | 7.06% |
| i3 Verticals | Buy | 12.38% | $35.17M | 3.35% |
| Similarweb | Outperform | 17.03% | $56.70M | -49.85% |
| Riskified | Neutral | 2.96% | $39.75M | -3.33% |
Financial Performance Indicators
Market Capitalization and Revenue Trends
Delving deeper into Docebo's finances provides a clearer picture of its operational standing. Despite having a lower market cap compared to peers, the company's revenue growth shows promise, boasting an impressive annual growth rate of 14.47%.
Profitability Metrics
Docebo's net margin stands at 5.06%, which falls below the industry average. Addressing profitability challenges may be crucial for sustained growth. However, the company boasts a healthy return on equity at 7.06%, indicating effective management of equity capital.
Asset and Debt Management
Boasting a return on assets (ROA) of 1.67%, Docebo exhibits effective asset utilization. Additionally, a debt-to-equity ratio below the industry average at 0.04 points to a prudent approach to financing, which is appealing to many investors.
Conclusion
Docebo’s upcoming earnings report is critical for investors. Balancing positive growth trends against profitability challenges presents both risks and opportunities, prompting close attention from stakeholders.
Frequently Asked Questions
What is Docebo's expected EPS for the upcoming report?
Analysts estimate Docebo's EPS to be $0.32 for the upcoming quarter.
How has Docebo's stock performed over the past year?
The shares of Docebo have decreased by 52.77% over the last 52-week period.
What is the general analyst consensus for Docebo?
The general consensus rating for Docebo is 'Buy' among analysts.
How do Docebo's financials compare with its peers?
Docebo ranks higher in revenue growth and gross profit compared to its peers but has the lowest return on equity ratio.
What is Docebo's market capitalization strategy?
Docebo employs a strategy that showcases effective asset utilization and a conservative debt management approach, positioning itself well in the industry.
